- Filed
- Nov 14, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2023 · Nov 14, 2023 | 21.04M sh |
| Cash And Equivalents | Q2 2023 · Sep 30, 2023 | $20.87M |
| Cash And Equivalents | Q2 2023 · Mar 31, 2023 | $25.27M |
| Current Liabilities | Q2 2023 · Sep 30, 2023 | $1.37M |
| Current Liabilities | Q2 2023 · Mar 31, 2023 | $4.65M |
| Total Liabilities | Q2 2023 · Sep 30, 2023 | $2.25M |
| Total Liabilities | Q2 2023 · Mar 31, 2023 | $5.91M |
| Current Assets | Q2 2023 · Sep 30, 2023 | $29.25M |
| Current Assets | Q2 2023 · Mar 31, 2023 | $31.1M |
| Total Assets | Q2 2023 · Sep 30, 2023 | $29.78M |
| Total Assets | Q2 2023 · Mar 31, 2023 | $31.37M |
| Shares Diluted restated | Q2 2023 · Sep 30, 2022 | 21.04M sh |
| Shares Diluted restated | Q2 2023 · Sep 30, 2022 | 21.04M sh |
| Capex | Q2 2023 · Sep 30, 2022 | $0 |
| Operating Cash Flow | Q2 2023 · Sep 30, 2022 | $2.2M |
| Stockholders Equity | Q2 2023 · Sep 30, 2022 | $25.59M |
| Stockholders Equity | Q2 2023 · Mar 31, 2022 | $26.82M |
| Eps Diluted | Q2 2023 · Sep 30, 2022 | −$0.01 |
| Eps Diluted | Q2 2023 · Sep 30, 2022 | −$0.06 |
| Eps Basic | Q2 2023 · Sep 30, 2022 | −$0.01 |
| Eps Basic | Q2 2023 · Sep 30, 2022 | −$0.06 |
| Sga Expense | Q2 2023 · Sep 30, 2022 | $1.29M |
| Sga Expense | Q2 2023 · Sep 30, 2022 | $2.64M |
| Net Income | Q2 2023 · Sep 30, 2022 | −$153K |
| Net Income | Q2 2023 · Sep 30, 2022 | −$1.23M |
| Operating Income | Q2 2023 · Sep 30, 2022 | −$300K |
| Operating Income | Q2 2023 · Sep 30, 2022 | −$1.45M |
| Cost Of Revenue | Q2 2023 · Sep 30, 2022 | $1.31M |
| Cost Of Revenue | Q2 2023 · Sep 30, 2022 | $2.19M |
| Revenue | Q2 2023 · Sep 30, 2022 | $2.3M |
| Revenue | Q2 2023 · Sep 30, 2022 | $3.37M |